Shih Diana M, Yu Janet M, Vergnes Laurent, Dali-Youcef Nassim, Champion Matthew D, Devarajan Asokan, Zhang Peixiang, Castellani Lawrence W, Brindley David N, Jamey Carole, Auwerx Johan, Reddy Srinivasa T, Ford David A, Reue Karen, Lusis Aldons J
*Division of Cardiology, Department of Medicine, Department of Microbiology, Immunology, and Molecular Genetics, Department of Human Genetics, Department of Molecular and Medical Pharmacology, and Department of Medicine and Molecular Biology Institute, University of California at Los Angeles, Los Angeles, California, USA; IGBMC, Illkirch and Hôpitaux Universitaires de Strasbourg, and **Laboratoire de Toxicologie, Universitaires de Strasbourg, Strasbourg, France; Department of Biochemistry and Molecular Biology, and Center for Cardiovascular Research, St. Louis University School of Medicine, St. Louis, Missouri, USA; University of Alberta, Edmonton, Alberta, Canada; and Laboratory for Integrative and Systems Physiology, School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland
*Division of Cardiology, Department of Medicine, Department of Microbiology, Immunology, and Molecular Genetics, Department of Human Genetics, Department of Molecular and Medical Pharmacology, and Department of Medicine and Molecular Biology Institute, University of California at Los Angeles, Los Angeles, California, USA; IGBMC, Illkirch and Hôpitaux Universitaires de Strasbourg, and **Laboratoire de Toxicologie, Universitaires de Strasbourg, Strasbourg, France; Department of Biochemistry and Molecular Biology, and Center for Cardiovascular Research, St. Louis University School of Medicine, St. Louis, Missouri, USA; University of Alberta, Edmonton, Alberta, Canada; and Laboratory for Integrative and Systems Physiology, School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.
FASEB J. 2015 Apr;29(4):1185-97. doi: 10.1096/fj.14-260570. Epub 2014 Dec 4.
We report the engineering and characterization of paraoxonase-3 knockout mice (Pon3KO). The mice were generally healthy but exhibited quantitative alterations in bile acid metabolism and a 37% increased body weight compared to the wild-type mice on a high fat diet. PON3 was enriched in the mitochondria-associated membrane fraction of hepatocytes. PON3 deficiency resulted in impaired mitochondrial respiration, increased mitochondrial superoxide levels, and increased hepatic expression of inflammatory genes. PON3 deficiency did not influence atherosclerosis development on an apolipoprotein E null hyperlipidemic background, but it did lead to a significant 60% increase in atherosclerotic lesion size in Pon3KO mice on the C57BL/6J background when fed a cholate-cholesterol diet. On the diet, the Pon3KO had significantly increased plasma intermediate-density lipoprotein/LDL cholesterol and bile acid levels. They also exhibited significantly elevated levels of hepatotoxicity markers in circulation, a 58% increase in gallstone weight, a 40% increase in hepatic cholesterol level, and increased mortality. Furthermore, Pon3KO mice exhibited decreased hepatic bile acid synthesis and decreased bile acid levels in the small intestine compared with wild-type mice. Our study suggests a role for PON3 in the metabolism of lipid and bile acid as well as protection against atherosclerosis, gallstone disease, and obesity.
我们报告了对氧磷酶3基因敲除小鼠(Pon3KO)的构建及特性研究。这些小鼠总体健康,但在高脂饮食条件下,其胆汁酸代谢出现定量改变,体重比野生型小鼠增加了37%。PON3在肝细胞的线粒体相关膜组分中富集。PON3缺乏导致线粒体呼吸受损、线粒体超氧化物水平升高以及肝脏炎症基因表达增加。在载脂蛋白E基因缺失的高脂血症背景下,PON3缺乏并不影响动脉粥样硬化的发展,但在C57BL/6J背景的Pon3KO小鼠喂食胆酸盐 - 胆固醇饮食时,确实导致动脉粥样硬化病变大小显著增加60%。在此饮食条件下,Pon3KO小鼠的血浆中密度脂蛋白/低密度脂蛋白胆固醇和胆汁酸水平显著升高。它们循环中的肝毒性标志物水平也显著升高,胆结石重量增加58%,肝脏胆固醇水平增加40%,死亡率上升。此外,与野生型小鼠相比,Pon3KO小鼠的肝脏胆汁酸合成减少,小肠胆汁酸水平降低。我们的研究表明PON3在脂质和胆汁酸代谢以及预防动脉粥样硬化、胆结石疾病和肥胖方面发挥作用。